Brainfarma Industria Química e Farmacêutica S/A clinical trials

A subsidiary of Hypera Pharma

The registry lists 14 studies whose lead sponsor is Brainfarma Industria Química e Farmacêutica S/A. 9 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 30, 2026.

Studies

Recruiting first, then most recently updated. Showing 14 of 14. All Hypera Pharma studies →

• Dermal Acceptability Evaluation in Sensitive SkinRecruitingNCT07848347Not applicable

  Sponsor listed in the registry: Brainfarma Industria Química e Farmacêutica S/A

• Dermal and Ophthalmological Acceptability and Comedogenicity Assessment of a Cosmetic ProductRecruitingNCT07848555Not applicable

  Sponsor listed in the registry: Brainfarma Industria Química e Farmacêutica S/A

• Pediatric Acceptability Evaluation of a Cosmetic ProductRecruitingNCT07839104Not applicable

  Sponsor listed in the registry: Brainfarma Industria Química e Farmacêutica S/A

• Evaluation of Dermal Acceptability and Comedogenic and Acnegenic Potential of a Cosmetic ProductRecruitingNCT07768800Not applicable

  Sponsor listed in the registry: Brainfarma Industria Química e Farmacêutica S/A

• Efficacy Evaluation of a Cosmetic Product for Facial HyperpigmentationRecruitingNCT07769268Not applicable

  Sponsor listed in the registry: Brainfarma Industria Química e Farmacêutica S/A

• Dermatological Acceptability and Efficacy in Improving Xerosis, Skin Hydration, and Barrier FunctionRecruitingNCT07820943Not applicable

  Sponsor listed in the registry: Brainfarma Industria Química e Farmacêutica S/A

• Dermal and Ophthalmological Acceptability Assessment in Sensitive SkinRecruitingNCT07771998Not applicable

  Sponsor listed in the registry: Brainfarma Industria Química e Farmacêutica S/A

• Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic NeuralgiaRecruitingNCT07712913Phase 3

  Sponsor listed in the registry: Brainfarma Industria Química e Farmacêutica S/A

• Fixed-dose Combination of 1000 mg Dipyrone Monohydrate + 60 mg Caffeine + 4 mg Chlorpheniramine Maleate in Improving Symptoms of the Common Cold and Flu in AdultsRecruitingNCT07626437Phase 3

  Sponsor listed in the registry: Brainfarma Industria Química e Farmacêutica S/A

• Evaluation of Allergenicity by HRIPT and PhototestCompletedNCT07797192Not applicable

  Sponsor listed in the registry: Brainfarma Industria Química e Farmacêutica S/A

• Efficacy and Safety Study of Nasal Lubricant Compared to Placebo on SnoringStatus unknownNCT05031585Not applicable

  Sponsor listed in the registry: Brainfarma Industria Química e Farmacêutica S/A

• Efficacy and Safety Study of Ibuprofen Gel Compared to Placebo in the Treatment of Acute Musculoskeletal PainStatus unknownNCT05013567Phase 3

  Sponsor listed in the registry: Brainfarma Industria Química e Farmacêutica S/A

• Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension.Status unknownNCT05110898Phase 3

  Sponsor listed in the registry: Brainfarma Industria Química e Farmacêutica S/A

• Study Comparing Coristina® D to Resfenol® in the Symptomatic Treatment of Common ColdStatus unknownNCT02735070Phase 3

  Sponsor listed in the registry: Brainfarma Industria Química e Farmacêutica S/A